GetTopicDetailResponse(id=8e5c33503d1, topicName=化學治療, introduction=化學治療, content=null, image=null, comments=4, allHits=1453, url=https://h5.medsci.cn/topic?id=33503, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=52881, tagList=[TagDto(tagId=52881, tagName=化學治療)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2198427, encodeId=b5ab219842ebd, content=<a href='/topic/show?id=78aa999190f' target=_blank style='color:#2F92EE;'>#靶向治療#</a> <a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治療#</a> <a href='/topic/show?id=8e5c33503d1' target=_blank style='color:#2F92EE;'>#化學治療#</a> <a href='/topic/show?id=fc5b108298c5' target=_blank style='color:#2F92EE;'>#膽道惡性腫瘤#</a>, objectTitle=晚期膽道惡性腫瘤藥物治療新進展, objectType=article, longId=818677, objectId=b2aa8186e738, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=b2aa8186e738, replyNumber=0, likeNumber=129, createdTime=2024-04-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b2aa8186e738, moduleTitle=晚期膽道惡性腫瘤藥物治療新進展, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b2aa8186e738)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1989699, encodeId=b8a31989699e1, content=<a href='/topic/show?id=8e5c33503d1' target=_blank style='color:#2F92EE;'>#化學治療#</a>, objectTitle=耐藥結(jié)核病化學治療指南（2019年簡版）, objectType=article, longId=181802, objectId=115b18180245, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115b18180245, replyNumber=0, likeNumber=87, createdTime=2020-04-23, rootId=0, userName=DEXTER3139, userId=6c32257, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115b18180245, moduleTitle=耐藥結(jié)核病化學治療指南（2019年簡版）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=115b18180245)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989698, encodeId=8ca019896985d, content=<a href='/topic/show?id=8e5c33503d1' target=_blank style='color:#2F92EE;'>#化學治療#</a>, objectTitle=Immunity：發(fā)現(xiàn)改善化學治療抗腫瘤效果新機制, objectType=article, longId=160144, objectId=5033160144ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5033160144ef, replyNumber=0, likeNumber=76, createdTime=2019-06-17, rootId=0, userName=DEXTER3139, userId=6c32257, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5033160144ef, moduleTitle=Immunity：發(fā)現(xiàn)改善化學治療抗腫瘤效果新機制, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5033160144ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989697, encodeId=0c04198969e4b, content=<a href='/topic/show?id=8e5c33503d1' target=_blank style='color:#2F92EE;'>#化學治療#</a>, objectTitle=PLOS ONE：十年眼科動脈化學治療經(jīng)驗：眼部無復(fù)發(fā)生存, objectType=article, longId=139100, objectId=e26213910032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e26213910032, replyNumber=0, likeNumber=96, createdTime=2018-07-05, rootId=0, userName=DEXTER3139, userId=6c32257, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e26213910032, moduleTitle=PLOS ONE：十年眼科動脈化學治療經(jīng)驗：眼部無復(fù)發(fā)生存, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e26213910032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989696, encodeId=5d5a198969675, content=<a href='/topic/show?id=8e5c33503d1' target=_blank style='color:#2F92EE;'>#化學治療#</a>, objectTitle=Cancer Res：烷基化的化學治療劑替莫唑胺能夠誘發(fā)IDH1突變腫瘤的代謝應(yīng)激并強化NAD+損耗介導的細胞毒性, objectType=article, longId=102901, objectId=463910290169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=463910290169, replyNumber=0, likeNumber=82, createdTime=2017-11-19, rootId=0, userName=DEXTER3139, userId=6c32257, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=463910290169, moduleTitle=Cancer Res：烷基化的化學治療劑替莫唑胺能夠誘發(fā)IDH1突變腫瘤的代謝應(yīng)激并強化NAD+損耗介導的細胞毒性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=463910290169)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
